New Jersey 2022-2023 Regular Session

New Jersey Senate Bill SCR54

Introduced
1/31/22  

Caption

Urges U.S. President, Congress, and Department of Health and Human Services to ease patient limits applicable to private physicians prescribing buprenorphine as part of medication-assisted treatment for substance use disorders.

Companion Bills

No companion bills found.

Similar Bills

CA AB2384

Medication-assisted treatment.

CA SB554

Nurse practitioners: physician assistants: buprenorphine.

KY HB788

AN ACT relating to buprenorphine products.

MA H3486

Resolutions urging the Congress of the United States to update the Drug Addiction Treatment Act of 2000 and remove excessive training requirements mandated for obtaining a waiver to prescribe buprenorphine

MA H3827

Resolutions urging the Congress of the United States to update the Drug Addiction Treatment Act of 2000 and remove excessive training requirements mandated for obtaining a waiver to prescribe buprenorphine

TN SB2297

AN ACT to amend Tennessee Code Annotated, Title 33; Title 53; Title 63 and Title 68, relative to the use of buprenorphine products.

TN HB2308

AN ACT to amend Tennessee Code Annotated, Title 33; Title 53; Title 63 and Title 68, relative to the use of buprenorphine products.

TN SB0421

AN ACT to amend Tennessee Code Annotated, Title 33; Title 41; Title 53 and Title 63, relative to healthcare prescribers.